​
Login / Signup
Emily Mason-Osann
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Acute Myeloid Leukemia
Squamous Cell
Adverse Drug
Induced Apoptosis
Top Venues
Blood cancer discovery
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Emily Mason-Osann
,
Amy E Pomeroy
,
Adam C Palmer
,
Jerome T Mettetal
SYNERGISTIC DRUG COMBINATIONS PROMOTE THE DEVELOPMENT OF RESISTANCE IN ACUTE MYELOID LEUKEMIA.
Blood cancer discovery
(2024)
Emily Mason-Osann
,
Amy E Pomeroy
,
Adam C Palmer
,
Jerome T Mettetal
SYNERGISTIC DRUG COMBINATIONS PROMOTE THE DEVELOPMENT OF RESISTANCE IN ACUTE MYELOID LEUKEMIA.
Blood cancer discovery
(2024)
Emily Mason-Osann
,
Amy E Pomeroy
,
Adam C Palmer
,
Jerome T Mettetal
Synergistic Drug Combinations Promote the Development of Resistance in Acute Myeloid Leukemia.
Blood cancer discovery
5 (2) (2024)
Emily Mason-Osann
,
Amy E Pomeroy
,
Adam C Palmer
,
Jerome T Mettetal
Synergistic Drug Combinations Promote the Development of Resistance in Acute Myeloid Leukemia.
Blood cancer discovery
5 (2) (2024)